MK0557

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MK0557, covering 2015-08-21 to 2016-09-16. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED) [Phase 2]